Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Thoracic 1Sarcoma 1Gynecologic 1Genitourinary 1Dermatologic 1

Conditions

Glioblastoma 114Brain Neoplasms 111Glioma 91Neuroblastoma 35Neoplasms 27Astrocytoma 27Neurofibromatosis 1 25Medulloblastoma 25Central Nervous System Neoplasms 25Meningioma 23Ependymoma 23Sarcoma 22Melanoma 18Breast Neoplasms 18Rhabdoid Tumor 16Carcinoma, Non-Small-Cell Lung 16Osteosarcoma 15Neurofibroma, Plexiform 15Rhabdomyosarcoma 14Wilms Tumor 13Sarcoma, Ewing 13Thyroid Neoplasms 12Hepatoblastoma 12Gliosarcoma 12Diffuse Intrinsic Pontine Glioma 12Recurrence 11Pheochromocytoma 10Pancreatic Neoplasms 10Oligodendroglioma 10Neoplasm Metastasis 10

Interventions

enasidenib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Sinonasal undifferentiated carcinoma × CNS × 30 days × Clear all
NCT06176989 2026-06-03

Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors

National Institutes of Health Clinical Center (CC)

Phase 2 Recruiting
40 enrolled
CNSSarcoma

Sinonasal undifferentiated carcinoma, Chondrosarcoma, Esthesioneuroblastoma, Olfactory

NCT06814496 2026-05-20

RABBIT

University of Arizona

Phase 1/2 Recruiting
30 enrolled
CNSDermatologicGenitourinaryGynecologicThoracic

Sinonasal undifferentiated carcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Glioblastoma, Melanoma, Testicular Neoplasms, Carcinoma, Merkel Cell, Carcinoma, Medullary, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡